REPRODUCIBILITY OF ONE-STAGE, 2-STAGE AND CHROMOGENIC ASSAYS OF FACTOR-VIII ACTIVITY - A MULTICENTER STUDY

被引:14
作者
CINOTTI, S
LONGO, G
MESSORI, A
MORFINI, M
BLOMBACK, M
SCHIMPF, K
SCHUMACHER, K
KJELLMAN, H
NOVAKOVABANET, A
DELVOS, U
机构
[1] BEHRINGWERKE AG,RES LABS,W-3550 MARBURG,GERMANY
[2] REHABIL HOSP,HEIDELBERG,GERMANY
[3] HEMOPHILIA CTR,HEIDELBERG,GERMANY
[4] REHABIL FDN,HEIDELBERG,GERMANY
[5] USL 10D,CTR HEMOPHILIA,I-50134 FLORENCE,ITALY
[6] KAROLINSKA HOSP,DEPT CLIN CHEM & BLOOD COAGULAT,S-10401 STOCKHOLM 60,SWEDEN
[7] USL 10D,PHARMACEUT SERV,FLORENCE,ITALY
关键词
FACTOR-VIII ASSAY; REPRODUCIBILITY; COAGULATION INSTRUMENTS;
D O I
10.1016/0049-3848(91)90652-D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was aimed at assessing the reproducibility of Factor VIII assays between different laboratories using the same reagents. A total of 176 post-dose plasma samples were obtained from 8 Italian subjects with hemophilia-A treated with a single dose of Factor VIII concentrates. Three laboratories (in FRG, Italy, and Sweden) participated in the study. Frozen aliquots of each sample were dispatched to each of the laboratories, where the aliquots were assayed using the same one-stage, two-stage and chromogenic methods. The one-stage and the chromogenic methods were well reproducible between the three centers: pairwise correlation analyses yielded r-values ranging from 0.88 to 0.91 for the one-stage method and from 0.91 to 0.96 for the chromogenic method. The agreement between these two assays was less evident in samples with activity below 200 IU/L in which the one-stage gave, on average, higher Factor VIII concentrations than those provided by the chromogenic method. The two-stage method was not well reproducible, and the pairwise r-values ranged from 0.48 to 0.73. Our study emphasises the need to develop multi-center quality control programs to verify the reproducibility of Factor VIII assays.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 19 条
[1]   STANDARDIZATION OF FACTOR-VIII .1. CALIBRATION OF BRITISH STANDARDS FOR FACTOR-VIII CLOTTING ACTIVITY [J].
BARROWCLIFFE, TW ;
KIRKWOOD, TBL .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 46 (03) :471-481
[2]  
BARROWCLIFFE TW, 1978, THROMB HAEMOSTASIS, V40, P260
[3]  
BERNTORP E, 1988, EUR J HAEMATOL, V40, P205
[4]  
BLOMBACK M, 1987, SCAND J CLIN LAB INV, V47, P561
[5]  
BLOMBACK M, 1990, 19 INT C WORLD FED H
[6]  
DENSON KWE, 1976, HUMAN BLOOD COAGULAT, P688
[7]  
FINNEY DJ, 1952, STATISTICAL METHOD B
[8]   QUALITY-CONTROL IN DRUG MEASUREMENT [J].
GRIFFITHS, A ;
HEBDIGE, S ;
PERUCCA, E ;
RICHENS, A .
THERAPEUTIC DRUG MONITORING, 1980, 2 (01) :51-59
[9]  
HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215
[10]  
HEIMBURGER N, 1981, ARZNEIMITTEL-FORSCH, V31-1, P619